Inventor · disambiguated record
Nils Brunner
Also filed as: BRUENNER NILS · BRUENNER NILS AAGE · BRUNNER NILS · BRUNNER NILS A
7 granted patents·14 pending applications·30 citations·filing 1994–2021
82Inventor score
Files withRIGSHOSPITALET5SCANDION ONCOLOGY AS3HVIDOVRE HOSPITAL2BRUENNER NILS AAGE1CANCERFORSKNINGSFONDEN AF 19891
Top patents by PatentIndex Score
21 records- 0172US7807379B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2006·Granted Oct 5, 2010·3 cites·29 claims
- 0271US7108983B1Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2000·Granted Sep 19, 2006·11 cites·19 claims
- 0370US11103481B2Combination treatment of cancerSCANDION ONCOLOGY AS·Filed 2017·Granted Aug 31, 2021·2 cites·31 claims
- 0463US2008171691A1Inhibition of invasive remodellingLUND LEIF ROGE·Filed 2008·Application pending·0 cites
- 0560US11903927B2Combination treatment of cancerSCANDION ONCOLOGY AS·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 0656US2005137121A1Inhibition of invasive remodellingFiled 2004·Application pending·0 cites
- 0756US2009035794A1Method for detecting, screening, and/or monitoring cancer in an individualRIGSHOSPITALET PUBLIC UNIVERSI·Filed 2008·Application pending·0 cites
- 0854US2008261246A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2008·Application pending·0 cites
- 0951US2011144047A1Combined method for predicting the response to an anti-cancer therapyDAKO DENMARK AS·Filed 2009·Application pending·0 cites
- 1050US2011294148A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerHOLTEN-ANDERSEN MADS NIKOLAJ·Filed 2011·Application pending·0 cites
- 1150US2011060529A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer markerRIGSHOSPITALET·Filed 2010·Application pending·0 cites
- 1249US7374886B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2002·Granted May 20, 2008·1 cites·31 claims
- 1349US2002099004A1Inhibition of invasive remodellingFiled 2001·Application pending·0 cites
- 1446US2021251963A1Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1SCANDION ONCOLOGY AS·Filed 2019·Application pending·0 cites
- 1545US2011165577A1Selection of colorectal cancer patients for neo-adjuvant and adjuvent systemic anti-cancer treatmentBRUENNER NILS AAGE·Filed 2009·Application pending·0 cites
- 1645US2002012950A1Pai-1 determination and use thereofFiled 2001·Application pending·0 cites
- 1742US2006014224A1Method for detecting, screening and/or monitoring a cancer in an individualHVIDOVRE HOSPITAL·Filed 2003·Application pending·0 cites
- 1840US2006154245A1Method for detecting, screening and/or montoring a cancer in individualHVIDOVRE HOSPITAL·Filed 2005·Application pending·0 cites
- 1938US6224865B1Suppression of inhibitorsCANCERFORSKNINGSFONDEN AF 1989·Filed 1994·Granted May 1, 2001·8 cites·24 claims
- 2032US6271352B1PAI-1 determination and use thereofFONDEN TIL FREMME AF EKSPERIME·Filed 1995·Granted Aug 7, 2001·5 cites·21 claims
- 2126US2008019910A1Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease InhibitorsROMER MARIA U·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nils Brunner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →